YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
DEFECTIVE DRUGS
Parker Waichman Alonso LLP is a leader in a defective drug litigation. We are currently evaluating cases involving the prescription drugs listed below. Please click on a specific drug or fill out the form at the right for a free case evaluation by a qualified attorney.
Defective Drugs
Defective Drugs NewsRSS Feed
Vicks Sinex Nasal Spray Recalled Over Bacterial Contamination
Nov 20, 2009 | Parker Waichman Alonso LLP
Vicks Sinex nasal spray is being recalled in three countries because of potential bacterial contamination. According to a recall notice...
Dialysis, Kidney Transplant Patients Face Higher Risk of NSF from Gadolinium Agents
Nov 20, 2009 | Parker Waichman Alonso LLP
A study of patients exposed to gadolinium contrast dyes at the Mayo Clinic has revealed that hemodialysis patients had a 77-fold higher...
OptiMARK Gadolinium Contrast Agent Label Changed Over NSF Risk
Nov 19, 2009 | Parker Waichman Alonso LLP
The maker of OptiMARK gadolinium contrast agent is modifying the product's label to contraindicate its use in patients with severe kidney impairment...
Plavix Users Warned Not to Take Prilosec, Nexium
Nov 18, 2009 | Parker Waichman Alonso LLP
Prilosec and Nexium reduce the anti-clotting effects of Plavix, according to a Public Health Advisory issued by the U.S. Food & Drug...
Gardasil No Longer Requirement For Immigrants
Nov 18, 2009 | Parker Waichman Alonso LLP
Gardasil or other HPV vaccination will no longer be a requirement for immigrant girls and women seeking a green card, according to the Associated...
Magnevist, Omniscan and OptiMARK Have Highest Risk of NSF, FDA Says
Nov 18, 2009 | Parker Waichman Alonso LLP
Three gadolinium contrast dyes - Bayer Healthcare's Magnevist, GE Healthcare's Omniscan, and Covidien 's OptiMARK -carry a higher risk of...
FDA Says Shire, Eisai Drug Promotions Misleading
Nov 17, 2009 | Parker Waichman Alonso LLP
News media are reporting that the U.S. Food and Drug Administration (FDA) has issued warning letters to Shire PLC and Eisai Co Ltd about drug...
Reports Of Cartilage Damage Associated With Local Anesthetics, Pain Pumps
Nov 16, 2009 | Parker Waichman Alonso LLP
Orthopedic and anesthesia healthcare professionals and hospital risk managers are being advised by the U.S. Food and Drug Administration (FDA) of 35...
Genzyme Drugs Found To Be Tainted With Steel Fragments, Other Foreign Matter
Nov 16, 2009 | Parker Waichman Alonso LLP
The U.S. Food and Drug Administration and Genzyme Corporation are advising endocrinological and genetics medicine healthcare professionals that...
Vytorin, Zetia Disappoint Again
Nov 16, 2009 | Parker Waichman Alonso LLP
Vytorin and Zetia, Merck & Co.'s anti-cholesterol medications, are coming under fire again. A new study has found that a much older - and...
Yaz, Yaz Litigation Progresses, Plaintiffs' Steering Committee Named
Nov 12, 2009 | Parker Waichman Alonso LLP
There is progress to report in the Yaz and Yasmin multidistrict litigation (MDL No. 2100) currently underway in U.S. District Court for the...
Illness Reported After H1N1 Vaccine
Nov 12, 2009 | Parker Waichman Alonso LLP
Less than 24 hours after being inoculated against the H1N1 Swine Flu, a young Virginia boy has come down with the dangerous, often debilitating...
Defective Drugs


